DEA Raises Production Levels For Psychedelics, Deschedules Cocaine-Derived Drug, Could Cannabis Be Next?

The Drug Enforcement Administration (DEA) raised legal production quotas for illegal Schedule I drugs like psilocybin, MDMA and DMT…again. The agency first set its initial targets for psychedelics to be produced for research activities in the U.S. earlier this year, and then raised those numbered in September, opening a public comment period, writes Marijuana Moment.

Now, after the public comment period is over and the DEA reviewed the feedback, it has once again boosted legal production quotas for these substances.

The new quota for psilocybin is 6kg by the end of the year, which is quadruple the previous figure.

When it comes to MDMA and DMT, its final quotas rose 6,300%, with the DEA aiming to have 3.2 kg produced by the end of the year. 

“DEA acknowledges the expressions of appreciation to changes in the [Aggregate Production …

Full story available on Benzinga.com

More DEA Raises Production Levels For Psychedelics, Deschedules Cocaine-Derived Drug, Could Cannabis Be Next?